PEGylation of Octreotide: II. Effect of N-terminal Mono-PEGylation on Biological Activity and Pharmacokinetics

By Na Dong Hee   Lee Kang Choon   DeLuca Patrick P.  

Pharmaceutical Research, Vol. 22, Iss. 5, 2005-05 ,pp. : 743-749

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics and Biodistribution of Novel Aptamer Compositions

By Healy Judith M.   Lewis Scott D.   Kurz Markus   Boomer Ryan M.   Thompson Kristin M.   Wilson Charles   McCauley Thomas G.  

Pharmaceutical Research, Vol. 21, Iss. 12, 2004-12 ,pp. : 2234-2246

Springer Publishing Company

Access to resources Recommend Favorite

Targeting a Genetic Killer: Novel Disease-Modifying Therapies for Cystic Fibrosis

By Adis International Limited  

Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 4, 2006-01 ,pp. : 10-13

Adis International

Access to resources Recommend Favorite

Clinical Pharmacology of Novel Anti-Alzheimer Disease Modifying Medications

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 15, 2013-08 ,pp. : 1853-1863

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Linezolid, a Novel Oxazolidinone Antibacterial

By Stalker D.J.   Jungbluth G.L.  

Clinical Pharmacokinetics, Vol. 42, Iss. 13, 2003-01 ,pp. : 1129-1140

Adis International

Access to resources Recommend Favorite